Amneal Pharmaceuticals Inc
NYSE:AMRX
Amneal Pharmaceuticals Inc
Other Current Assets
Amneal Pharmaceuticals Inc
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amneal Pharmaceuticals Inc
NYSE:AMRX
|
Other Current Assets
$59.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-1%
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Current Assets
$4.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-6%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Current Assets
$2B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
Pfizer Inc
NYSE:PFE
|
Other Current Assets
$4.4B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-6%
|
|
Merck & Co Inc
NYSE:MRK
|
Other Current Assets
$7.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
17%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Current Assets
$6.5B
|
CAGR 3-Years
26%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
See Also
What is Amneal Pharmaceuticals Inc's Other Current Assets?
Other Current Assets
59.3m
USD
Based on the financial report for Dec 31, 2023, Amneal Pharmaceuticals Inc's Other Current Assets amounts to 59.3m USD.
What is Amneal Pharmaceuticals Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
-1%
Over the last year, the Other Current Assets growth was 2%. The average annual Other Current Assets growth rates for Amneal Pharmaceuticals Inc have been 9% over the past three years , -7% over the past five years , and -1% over the past ten years .